List of Tables
Table 1. Global Interleukin Inhibitors for Psoriasis Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Interleukin Inhibitors for Psoriasis Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Interleukin Inhibitors for Psoriasis Market Competitive Situation by Manufacturers in 2023
Table 4. Global Interleukin Inhibitors for Psoriasis Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Interleukin Inhibitors for Psoriasis Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Interleukin Inhibitors for Psoriasis Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Interleukin Inhibitors for Psoriasis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Interleukin Inhibitors for Psoriasis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Interleukin Inhibitors for Psoriasis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Interleukin Inhibitors for Psoriasis, Product Type & Application
Table 12. Global Key Manufacturers of Interleukin Inhibitors for Psoriasis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Interleukin Inhibitors for Psoriasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin Inhibitors for Psoriasis as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Interleukin Inhibitors for Psoriasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Interleukin Inhibitors for Psoriasis Sales by Region (2019-2024) & (K Units)
Table 18. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Region (2019-2024)
Table 19. Global Interleukin Inhibitors for Psoriasis Sales by Region (2025-2030) & (K Units)
Table 20. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Region (2025-2030)
Table 21. Global Interleukin Inhibitors for Psoriasis Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Interleukin Inhibitors for Psoriasis Revenue Market Share by Region (2019-2024)
Table 23. Global Interleukin Inhibitors for Psoriasis Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Interleukin Inhibitors for Psoriasis Revenue Market Share by Region (2025-2030)
Table 25. North America Interleukin Inhibitors for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Interleukin Inhibitors for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 27. North America Interleukin Inhibitors for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 28. North America Interleukin Inhibitors for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Interleukin Inhibitors for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Interleukin Inhibitors for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Interleukin Inhibitors for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 32. Europe Interleukin Inhibitors for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 33. Europe Interleukin Inhibitors for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Interleukin Inhibitors for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Interleukin Inhibitors for Psoriasis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Interleukin Inhibitors for Psoriasis Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Interleukin Inhibitors for Psoriasis Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Interleukin Inhibitors for Psoriasis Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Interleukin Inhibitors for Psoriasis Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Interleukin Inhibitors for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Interleukin Inhibitors for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Interleukin Inhibitors for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Interleukin Inhibitors for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Interleukin Inhibitors for Psoriasis Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Interleukin Inhibitors for Psoriasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Interleukin Inhibitors for Psoriasis Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Interleukin Inhibitors for Psoriasis Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Interleukin Inhibitors for Psoriasis Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Interleukin Inhibitors for Psoriasis Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Interleukin Inhibitors for Psoriasis Sales (K Units) by Type (2019-2024)
Table 51. Global Interleukin Inhibitors for Psoriasis Sales (K Units) by Type (2025-2030)
Table 52. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Type (2019-2024)
Table 53. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Type (2025-2030)
Table 54. Global Interleukin Inhibitors for Psoriasis Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Interleukin Inhibitors for Psoriasis Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Interleukin Inhibitors for Psoriasis Revenue Market Share by Type (2019-2024)
Table 57. Global Interleukin Inhibitors for Psoriasis Revenue Market Share by Type (2025-2030)
Table 58. Global Interleukin Inhibitors for Psoriasis Price (US$/Unit) by Type (2019-2024)
Table 59. Global Interleukin Inhibitors for Psoriasis Price (US$/Unit) by Type (2025-2030)
Table 60. Global Interleukin Inhibitors for Psoriasis Sales (K Units) by Application (2019-2024)
Table 61. Global Interleukin Inhibitors for Psoriasis Sales (K Units) by Application (2025-2030)
Table 62. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Application (2019-2024)
Table 63. Global Interleukin Inhibitors for Psoriasis Sales Market Share by Application (2025-2030)
Table 64. Global Interleukin Inhibitors for Psoriasis Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Interleukin Inhibitors for Psoriasis Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Interleukin Inhibitors for Psoriasis Revenue Market Share by Application (2019-2024)
Table 67. Global Interleukin Inhibitors for Psoriasis Revenue Market Share by Application (2025-2030)
Table 68. Global Interleukin Inhibitors for Psoriasis Price (US$/Unit) by Application (2019-2024)
Table 69. Global Interleukin Inhibitors for Psoriasis Price (US$/Unit) by Application (2025-2030)
Table 70. Dalian Yawei Pharmaceutical Company Information
Table 71. Dalian Yawei Pharmaceutical Description and Business Overview
Table 72. Dalian Yawei Pharmaceutical Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Dalian Yawei Pharmaceutical Interleukin Inhibitors for Psoriasis Product
Table 74. Dalian Yawei Pharmaceutical Recent Developments/Updates
Table 75. Janssen Biotech Company Information
Table 76. Janssen Biotech Description and Business Overview
Table 77. Janssen Biotech Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Janssen Biotech Interleukin Inhibitors for Psoriasis Product
Table 79. Janssen Biotech Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Interleukin Inhibitors for Psoriasis Product
Table 84. Teva Recent Developments/Updates
Table 85. UCB Company Information
Table 86. UCB Description and Business Overview
Table 87. UCB Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. UCB Interleukin Inhibitors for Psoriasis Product
Table 89. UCB Recent Developments/Updates
Table 90. Eli Lilly Company Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Eli Lilly Interleukin Inhibitors for Psoriasis Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Interleukin Inhibitors for Psoriasis Product
Table 99. Novartis Recent Developments/Updates
Table 100. Ortho Dermatologics Company Information
Table 101. Ortho Dermatologics Description and Business Overview
Table 102. Ortho Dermatologics Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Ortho Dermatologics Interleukin Inhibitors for Psoriasis Product
Table 104. Ortho Dermatologics Recent Developments/Updates
Table 105. LEO Pharma Company Information
Table 106. LEO Pharma Description and Business Overview
Table 107. LEO Pharma Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. LEO Pharma Interleukin Inhibitors for Psoriasis Product
Table 109. LEO Pharma Recent Developments/Updates
Table 110. Kyowa Kirin Company Information
Table 111. Kyowa Kirin Description and Business Overview
Table 112. Kyowa Kirin Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Kyowa Kirin Interleukin Inhibitors for Psoriasis Product
Table 114. Kyowa Kirin Recent Developments/Updates
Table 115. Samsung Bioepis Company Information
Table 116. Samsung Bioepis Description and Business Overview
Table 117. Samsung Bioepis Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Samsung Bioepis Interleukin Inhibitors for Psoriasis Product
Table 119. Samsung Bioepis Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sun Pharma Interleukin Inhibitors for Psoriasis Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. China Medical System Company Information
Table 126. China Medical System Description and Business Overview
Table 127. China Medical System Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. China Medical System Interleukin Inhibitors for Psoriasis Product
Table 129. China Medical System Recent Developments/Updates
Table 130. Almirall Company Information
Table 131. Almirall Description and Business Overview
Table 132. Almirall Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Almirall Interleukin Inhibitors for Psoriasis Product
Table 134. Almirall Recent Developments/Updates
Table 135. AbbVie Biotechnology Company Information
Table 136. AbbVie Biotechnology Description and Business Overview
Table 137. AbbVie Biotechnology Interleukin Inhibitors for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. AbbVie Biotechnology Interleukin Inhibitors for Psoriasis Product
Table 139. AbbVie Biotechnology Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Interleukin Inhibitors for Psoriasis Distributors List
Table 143. Interleukin Inhibitors for Psoriasis Customers List
Table 144. Interleukin Inhibitors for Psoriasis Market Trends
Table 145. Interleukin Inhibitors for Psoriasis Market Drivers
Table 146. Interleukin Inhibitors for Psoriasis Market Challenges
Table 147. Interleukin Inhibitors for Psoriasis Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Interleukin Inhibitors for Psoriasis
Figure 2. Global Interleukin Inhibitors for Psoriasis Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Interleukin Inhibitors for Psoriasis Market Share by Type: 2023 & 2030
Figure 4. Interleukin-8 Inhibitors Product Picture
Figure 5. Interleukin-12 Inhibitors Product Picture
Figure 6. Interleukin-17 Inhibitors Product Picture
Figure 7. Interleukin-23 Inhibitors Product Picture
Figure 8. Other Product Picture
Figure 9. Global Interleukin Inhibitors for Psoriasis Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Interleukin Inhibitors for Psoriasis Market Share by Application: 2023 & 2030
Figure 11. Hospital and Clinic
Figure 12. Retail Pharmacies
Figure 13. Other
Figure 14. Global Interleukin Inhibitors for Psoriasis Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Interleukin Inhibitors for Psoriasis Market Size (2019-2030) & (US$ Million)
Figure 16. Global Interleukin Inhibitors for Psoriasis Sales (2019-2030) & (K Units)
Figure 17. Global Interleukin Inhibitors for Psoriasis Average Price (US$/Unit) & (2019-2030)
Figure 18. Interleukin Inhibitors for Psoriasis Report Years Considered
Figure 19. Interleukin Inhibitors for Psoriasis Sales Share by Manufacturers in 2023
Figure 20. Global Interleukin Inhibitors for Psoriasis Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Interleukin Inhibitors for Psoriasis Players: Market Share by Revenue in Interleukin Inhibitors for Psoriasis in 2023
Figure 22. Interleukin Inhibitors for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Interleukin Inhibitors for Psoriasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Interleukin Inhibitors for Psoriasis Sales Market Share by Country (2019-2030)
Figure 25. North America Interleukin Inhibitors for Psoriasis Revenue Market Share by Country (2019-2030)
Figure 26. United States Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Interleukin Inhibitors for Psoriasis Sales Market Share by Country (2019-2030)
Figure 29. Europe Interleukin Inhibitors for Psoriasis Revenue Market Share by Country (2019-2030)
Figure 30. Germany Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Interleukin Inhibitors for Psoriasis Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Interleukin Inhibitors for Psoriasis Revenue Market Share by Region (2019-2030)
Figure 37. China Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Interleukin Inhibitors for Psoriasis Sales Market Share by Country (2019-2030)
Figure 45. Mexico Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Interleukin Inhibitors for Psoriasis Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Interleukin Inhibitors for Psoriasis Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Interleukin Inhibitors for Psoriasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Interleukin Inhibitors for Psoriasis by Type (2019-2030)
Figure 55. Global Revenue Market Share of Interleukin Inhibitors for Psoriasis by Type (2019-2030)
Figure 56. Global Interleukin Inhibitors for Psoriasis Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Interleukin Inhibitors for Psoriasis by Application (2019-2030)
Figure 58. Global Revenue Market Share of Interleukin Inhibitors for Psoriasis by Application (2019-2030)
Figure 59. Global Interleukin Inhibitors for Psoriasis Price (US$/Unit) by Application (2019-2030)
Figure 60. Interleukin Inhibitors for Psoriasis Value Chain
Figure 61. Interleukin Inhibitors for Psoriasis Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
